When was Optina founded?

Optina was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Where is Optina located?

Optina is headquartered in Montreal, Canada.

Is Optina a funded company?

Optina is a funded company, having raised a total of $23.7M across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 26, 2015.

When was the latest funding round of Optina?

Optina's latest funding was a $***** Series A round on Jan 24, 2022, with participation from 1 investor. Its primary sector is Healthcare IT. In Canada, the Healthcare IT sector has seen $117M in funding in 2026 to date.

Where does Optina rank among its competitors?

Optina ranks 9th amongst 52 active competitors, of which 18 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was PeriVision, which secured $3M in Sep, 2025.

Who are the top competitors of Optina?

Optina's top competitors include Remidio, PeriVision and Heru. Among them, PeriVision secured the most recent funding round in September, 2025.

Optina - 2026 Company Profile, Funding & Competitors

Company Details

Provider of AI-driven clinical decision support for retinal disease diagnosis. This involves using a hyperspectral camera and AI capabilities to aid eye specialists in the accurate diagnosis and management of early, intermediate, and late-stage retinal diseases. The system facilitates early detection, enabling timely interventions and a patient-centric approach to care. It helps identify high-risk patients before vision loss occurs and monitors disease progression.

Website: www.optina.net/
Email ID: *****@optinadx.com

Key Metrics

Founded Year

2011

Location

Montreal, Canada

Stage

Series A

Total Funding

$23.7M in 5 rounds

Latest Funding Round

Series A, Jan 24, 2022, $*****

Investors

Alzheimer's Drug Discovery & 11 more

Ranked

9^th among 52 active competitors

Similar Companies

Remidio & 55 more

View Optina's full profile

Optina has raised a total funding of $23.7M over 5 rounds. Its first funding round was on May 26, 2015. Its latest funding round was a Series A round on Jan 24, 2022 for $*****. 1 investor participated in its latest round. Optina has 11 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Optina:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 24, 2022	9116943	Series A	1662290	2867400	7284528	6182742
Oct 28, 2021	1118533	Series A	2706010	3218178	2514209	Boehringer Ingelheim Venture Fund & 3 more
May 13, 2020	5668595	Seed	3822066	7058000	3553414	1308458

Access funding benchmarks and valuations. Sign up today!

View details of Optina's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Optina include Remidio, PeriVision and Heru. Here is the list of Top 10 competitors of Optina, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Remidio 2009, Bengaluru (India), Series B	Developer of AI-powered portable digital solutions for ophthalmic screening and diagnosis	$25M	Montane Ventures, KITVEN & 32 others	65/100
2nd	PeriVision 2019, Epalinges (Switzerland), Seed	SaaS and AI based vision care clinical workflow for professionals and patients	$4.69M	Swiss ICT Investor Club, DART Ventures & 11 others	57/100
3rd	Heru 2018, Miami (United States), Series A	AI-based medical vision diagnostic device and platform	$36.7M	Open Opportunity Fund, Krillion Ventures & 3 others	56/100
4th	Optain 2023, New York City (United States), Series A	AI-powered retinal imaging technology for non-invasive evaluation of patients	$38M	Insight Partners, Lumio Capital & 8 others	54/100
5th	AIOptics 2020, New York (United States), Series B	Provider of AI-based digital platform and device to prevent blindness	$14.7M	Octane, HHS	49/100
6th	Intelligent Retinal Imaging Systems 2011, Pensacola (United States), Acquired	Telemedicine system for the early detection of diabetic eye disease	$13.3M	Ballast Point Ventures, Allumia Ventures & 1 others	48/100
7th	Topconhealthcare 2018, Oakland (United States), Unfunded	-	-	-	47/100
8th	Oivi 2017, Oslo (Norway), Seed	Online platform for tracking eye diseases through teleconsultation	$500K	Arali Ventures, EIC Fund & 6 others	46/100
9th	Optina 2011, Montreal (Canada), Series A	Provider of AI-driven clinical decision support for retinal disease diagnosis	$23.7M	Advisors.Fund, Boehringer Ingelheim Venture Fund ... & 10 others	37/100
10th	RETINA-AI Health 2017, Houston (United States), Series A	AI-powered device for diabetic retinopathy screening	$10.3M	30A Investment Partners, Village Seed Ventures ... & 1 others	37/100